rewirebio.iobenchmarks
Dataset

KIBA holdout test fold (DeepDTA split)

KIBA kinase inhibitor bioactivity dataset filtered as in He et al. 2017: 2,111 drugs, 229 proteins, 118,254 KIBA scores; predefined DeepDTA holdout test fold.

Evaluation results

16 evaluations · 32 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: DeepDTA with 1D conv. protein and 1D conv. drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.863 Concordance index (KIBA DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Evaluation origin not reported · Source checked
Methods, coverage and source

DeepDTA (1D conv.; 1D conv.) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'DeepDTA' with protein '1D conv.' and drug '1D conv.', column 'CI' (text-layer line 585)
Configuration: DeepDTA with 1D conv. protein and 1D conv. drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.194 MSE (KIBA DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Evaluation origin not reported · Source checked
Methods, coverage and source

DeepDTA (1D conv.; 1D conv.) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'DeepDTA' with protein '1D conv.' and drug '1D conv.', column 'MSE' (text-layer line 585)
Configuration: DeepGraphDTA with 1D conv. (16) protein and GIN drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.888 Concordance index (KIBA DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

DeepGraphDTA (1D conv. (16); GIN) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'DeepGraphDTA' with protein '1D conv. (16)' and drug 'GIN', column 'CI' (text-layer line 594)
Configuration: DeepGraphDTA with 1D conv. (16) protein and GIN drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.145 MSE (KIBA DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

DeepGraphDTA (1D conv. (16); GIN) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'DeepGraphDTA' with protein '1D conv. (16)' and drug 'GIN', column 'MSE' (text-layer line 594)
Configuration: DeepGraphDTA with 1D conv. (24) protein and GAT drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.872 Concordance index (KIBA DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

DeepGraphDTA (1D conv. (24); GAT) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'DeepGraphDTA' with protein '1D conv. (24)' and drug 'GAT', column 'CI' (text-layer line 593)
Configuration: DeepGraphDTA with 1D conv. (24) protein and GAT drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.173 MSE (KIBA DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

DeepGraphDTA (1D conv. (24); GAT) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'DeepGraphDTA' with protein '1D conv. (24)' and drug 'GAT', column 'MSE' (text-layer line 593)
Configuration: DeepGraphDTA with 1D conv. (32) protein and GAT-GCN drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.903 Concordance index (KIBA DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

DeepGraphDTA (1D conv. (32); GAT-GCN) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'DeepGraphDTA' with protein '1D conv. (32)' and drug 'GAT-GCN', column 'CI' (text-layer line 598)
Configuration: DeepGraphDTA with 1D conv. (32) protein and GAT-GCN drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.125 MSE (KIBA DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

DeepGraphDTA (1D conv. (32); GAT-GCN) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'DeepGraphDTA' with protein '1D conv. (32)' and drug 'GAT-GCN', column 'MSE' (text-layer line 598)
Configuration: DeepGraphDTA with 1D conv. (8) protein and GCN drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.901 Concordance index (KIBA DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

DeepGraphDTA (1D conv. (8); GCN) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'DeepGraphDTA' with protein '1D conv. (8)' and drug 'GCN', column 'CI' (text-layer line 596)
Configuration: DeepGraphDTA with 1D conv. (8) protein and GCN drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.128 MSE (KIBA DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

DeepGraphDTA (1D conv. (8); GCN) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'DeepGraphDTA' with protein '1D conv. (8)' and drug 'GCN', column 'MSE' (text-layer line 596)
Configuration: GraphDTA with 1D conv. protein and GAT-GCN drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.89 Concordance index (KIBA DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Evaluation origin not reported · Source checked
Methods, coverage and source

GraphDTA (1D conv.; GAT-GCN) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'GraphDTA' with protein '1D conv.' and drug 'GAT-GCN', column 'CI' (text-layer line 589)
Configuration: GraphDTA with 1D conv. protein and GAT-GCN drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.145 MSE (KIBA DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Evaluation origin not reported · Source checked
Methods, coverage and source

GraphDTA (1D conv.; GAT-GCN) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'GraphDTA' with protein '1D conv.' and drug 'GAT-GCN', column 'MSE' (text-layer line 589)
Configuration: GraphDTA with 1D conv. protein and GAT drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.866 Concordance index (KIBA DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Evaluation origin not reported · Source checked
Methods, coverage and source

GraphDTA (1D conv.; GAT) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'GraphDTA' with protein '1D conv.' and drug 'GAT', column 'CI' (text-layer line 586)
Configuration: GraphDTA with 1D conv. protein and GAT drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.178 MSE (KIBA DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Evaluation origin not reported · Source checked
Methods, coverage and source

GraphDTA (1D conv.; GAT) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'GraphDTA' with protein '1D conv.' and drug 'GAT', column 'MSE' (text-layer line 586)
Configuration: GraphDTA with 1D conv. protein and GCN drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.892 Concordance index (KIBA DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Evaluation origin not reported · Source checked
Methods, coverage and source

GraphDTA (1D conv.; GCN) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'GraphDTA' with protein '1D conv.' and drug 'GCN', column 'CI' (text-layer line 590)
Configuration: GraphDTA with 1D conv. protein and GCN drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.144 MSE (KIBA DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Evaluation origin not reported · Source checked
Methods, coverage and source

GraphDTA (1D conv.; GCN) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'GraphDTA' with protein '1D conv.' and drug 'GCN', column 'MSE' (text-layer line 590)
Configuration: GraphDTA with 1D conv. protein and GIN drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.884 Concordance index (KIBA DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Evaluation origin not reported · Source checked
Methods, coverage and source

GraphDTA (1D conv.; GIN) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'GraphDTA' with protein '1D conv.' and drug 'GIN', column 'CI' (text-layer line 588)
Configuration: GraphDTA with 1D conv. protein and GIN drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.149 MSE (KIBA DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Evaluation origin not reported · Source checked
Methods, coverage and source

GraphDTA (1D conv.; GIN) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'GraphDTA' with protein '1D conv.' and drug 'GIN', column 'MSE' (text-layer line 588)
Configuration: KronRLS with Similarity vector protein and Similarity vector drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.782 Concordance index (KIBA DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Evaluation origin not reported · Source checked
Methods, coverage and source

KronRLS (Similarity vector; Similarity vector) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'KronRLS' with protein 'Similarity vector' and drug 'Similarity vector', column 'CI' (text-layer line 583)
Configuration: KronRLS with Similarity vector protein and Similarity vector drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.411 MSE (KIBA DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Evaluation origin not reported · Source checked
Methods, coverage and source

KronRLS (Similarity vector; Similarity vector) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'KronRLS' with protein 'Similarity vector' and drug 'Similarity vector', column 'MSE' (text-layer line 583)
Configuration: PGraphDTA with ESM2 650M protein and GAT drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.872 Concordance index (KIBA DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Evaluation origin not reported · Source checked
Methods, coverage and source

PGraphDTA (ESM2 650M; GAT) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'PGraphDTA' with protein 'ESM2 650M' and drug 'GAT', column 'CI' (text-layer line 587)
Configuration: PGraphDTA with ESM2 650M protein and GAT drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.16 MSE (KIBA DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Evaluation origin not reported · Source checked
Methods, coverage and source

PGraphDTA (ESM2 650M; GAT) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'PGraphDTA' with protein 'ESM2 650M' and drug 'GAT', column 'MSE' (text-layer line 587)
Configuration: PLM-GraphDTA with ESMC 600M protein and GIN drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.888 Concordance index (KIBA DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

PLM-GraphDTA (ESMC 600M; GIN) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'PLM-GraphDTA' with protein 'ESMC 600M' and drug 'GIN', column 'CI' (text-layer line 595)
Configuration: PLM-GraphDTA with ESMC 600M protein and GIN drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.143 MSE (KIBA DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

PLM-GraphDTA (ESMC 600M; GIN) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'PLM-GraphDTA' with protein 'ESMC 600M' and drug 'GIN', column 'MSE' (text-layer line 595)
Configuration: PLM-GraphDTA with ProstT5 protein and GAT-GCN drug representationProtocol: KIBA drug-target affinity, DeepDTA holdout fold
Dataset: KIBA holdout test fold (DeepDTA split)
0.904 Concordance index (KIBA DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

PLM-GraphDTA (ProstT5; GAT-GCN) on KIBA

lit-interactions-20261011-plmdta-protocol-kiba-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 3, row 'PLM-GraphDTA' with protein 'ProstT5' and drug 'GAT-GCN', column 'CI' (text-layer line 599)

Source checking is not independent reproduction. Release 2026-10-22-1b7cf027e4f6.

Research readiness

0 of 4 readiness checks met. These checks assess whether the evidence supports a reproducible investigation; a source-checked score alone does not meet them.

Readiness checks, gaps and artifacts

Release 2026-10-22-1b7cf027e4f6 · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified
  • Sample annotations are recorded: not yet verified
  • Dependence between samples is assessed: not yet verified

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • A pinned run recipe exists: not yet verified
  • Compute requirements are estimated: not yet verified

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Independent validation data exist: not yet verified
  • Overlap with training data is checked: not yet verified

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Dataset and evaluation context

A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

5 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-22-1b7cf027e4f6
Property and statementOriginal source and locationReview and provenance
Source location
Section 3.1.2; Section 3.4
Context-only references
Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction

Original source ↗

Section 3.1.2; Section 3.4

Version: bioRxiv 10.64898/2026.08.31.748056v1 (posted 2026-09-03); 24-page PDF
Retrieved: 2026-10-11T21:27:40Z

not individually reviewed

No individual claim review recorded

Source has a recorded evidence concern. Consult its source page before using the claim.

Audit details

Field: attributes.source_locator

Source artifact SHA-256: 11b88d5ab2964b581430454d0d9e7848739819d52ec2e338e2a6412cbd259163

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Split
Predefined DeepDTA holdout test fold (train:test 5:1)
Context-only references
Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction

Original source ↗

Section 3.1.2; Section 3.4

Version: bioRxiv 10.64898/2026.08.31.748056v1 (posted 2026-09-03); 24-page PDF
Retrieved: 2026-10-11T21:27:40Z

not individually reviewed

No individual claim review recorded

Source has a recorded evidence concern. Consult its source page before using the claim.

Audit details

Field: attributes.split

Source artifact SHA-256: 11b88d5ab2964b581430454d0d9e7848739819d52ec2e338e2a6412cbd259163

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Version
DeepDTA repository data
Context-only references
Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction

Original source ↗

Section 3.1.2; Section 3.4

Version: bioRxiv 10.64898/2026.08.31.748056v1 (posted 2026-09-03); 24-page PDF
Retrieved: 2026-10-11T21:27:40Z

not individually reviewed

No individual claim review recorded

Source has a recorded evidence concern. Consult its source page before using the claim.

Audit details

Field: attributes.version

Source artifact SHA-256: 11b88d5ab2964b581430454d0d9e7848739819d52ec2e338e2a6412cbd259163

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Description
KIBA kinase inhibitor bioactivity dataset filtered as in He et al. 2017: 2,111 drugs, 229 proteins, 118,254 KIBA scores; predefined DeepDTA holdout test fold.
Context-only references
Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction

Original source ↗

Section 3.1.2; Section 3.4

Version: bioRxiv 10.64898/2026.08.31.748056v1 (posted 2026-09-03); 24-page PDF
Retrieved: 2026-10-11T21:27:40Z

not individually reviewed

No individual claim review recorded

Source has a recorded evidence concern. Consult its source page before using the claim.

Audit details

Field: description

Source artifact SHA-256: 11b88d5ab2964b581430454d0d9e7848739819d52ec2e338e2a6412cbd259163

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Name
KIBA holdout test fold (DeepDTA split)
Context-only references
Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction

Original source ↗

Section 3.1.2; Section 3.4

Version: bioRxiv 10.64898/2026.08.31.748056v1 (posted 2026-09-03); 24-page PDF
Retrieved: 2026-10-11T21:27:40Z

not individually reviewed

No individual claim review recorded

Source has a recorded evidence concern. Consult its source page before using the claim.

Audit details

Field: name

Source artifact SHA-256: 11b88d5ab2964b581430454d0d9e7848739819d52ec2e338e2a6412cbd259163

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Sources and history

Release 2026-10-22-1b7cf027e4f6 · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: lit-interactions-20261011-plmdta-data-kiba-deepdta-holdout

areas
molecular-interactions
contexts
research
version
DeepDTA repository data
split
Predefined DeepDTA holdout test fold (train:test 5:1)
source locator
Section 3.1.2; Section 3.4
Related records

Suggest a correction